224 related articles for article (PubMed ID: 23777362)
1. Prognostic value of the lymph node ratio after resection of periampullary carcinomas.
Farid SG; Falk GA; Joyce D; Chalikonda S; Walsh RM; Smith AM; Morris-Stiff G
HPB (Oxford); 2014 Jun; 16(6):582-91. PubMed ID: 23777362
[TBL] [Abstract][Full Text] [Related]
2. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the nodal status in ampullary carcinoma: the number of positive lymph nodes versus the lymph node ratio.
Sakata J; Shirai Y; Wakai T; Ajioka Y; Akazawa K; Hatakeyama K
World J Surg; 2011 Sep; 35(9):2118-24. PubMed ID: 21717240
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis.
van Rijssen LB; Narwade P; van Huijgevoort NC; Tseng DS; van Santvoort HC; Molenaar IQ; van Laarhoven HW; van Eijck CH; Busch OR; Besselink MG;
HPB (Oxford); 2016 Jul; 18(7):559-66. PubMed ID: 27346135
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.
Chen SC; Shyr YM; Chou SC; Wang SE
World J Surg Oncol; 2015 Jul; 13():224. PubMed ID: 26205252
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
11. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
[TBL] [Abstract][Full Text] [Related]
12. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
13. Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D; Chayeb H; Cataldegirmen G; Schurr PG; Kaifi JT; Mann O; Yekebas EF; Izbicki JR
J Gastrointest Surg; 2008 Nov; 12(11):1830-7; discussion 1837-8. PubMed ID: 18791769
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
15. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
18. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.
John BJ; Naik P; Ironside A; Davidson BR; Fusai G; Gillmore R; Watkins J; Rahman SH
HPB (Oxford); 2013 Sep; 15(9):674-80. PubMed ID: 23458477
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio versus number of affected lymph nodes as predictors of survival for resected pancreatic adenocarcinoma.
Bhatti I; Peacock O; Awan AK; Semeraro D; Larvin M; Hall RI
World J Surg; 2010 Apr; 34(4):768-75. PubMed ID: 20052471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]